Zosano Pharma Revenue and Competitors
Estimated Revenue & Valuation
- Zosano Pharma's estimated annual revenue is currently $7.5M per year.
- Zosano Pharma's estimated revenue per employee is $150,000
- Zosano Pharma's total funding is $242.6M.
Employee Data
- Zosano Pharma has 50 Employees.
- Zosano Pharma grew their employee count by 0% last year.
Zosano Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | VP Technical Operations | Reveal Email/Phone |
3 | VP, Clinical Development and Medical Affairs | Reveal Email/Phone |
4 | VP, Quality Assurance & Regulatory Affairs | Reveal Email/Phone |
5 | VP, Technical Operations | Reveal Email/Phone |
6 | Exec VP, CSO | Reveal Email/Phone |
7 | VP Research & Development | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Manager, Process Development | Reveal Email/Phone |
10 | Manager | Reveal Email/Phone |
Zosano Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $102.7M | 511 | 25% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $38.6M | 192 | 3% | N/A | N/A |
#4 | $35M | 127 | 2% | $62.5M | N/A |
#5 | $36.6M | 182 | 18% | N/A | N/A |
#6 | $131.9M | 656 | -3% | N/A | N/A |
#7 | $133.5M | 664 | N/A | N/A | N/A |
#8 | $72.8M | 362 | -4% | N/A | N/A |
#9 | $551.9M | 1716 | -2% | N/A | N/A |
#10 | $11.7M | 58 | 12% | N/A | N/A |
What Is Zosano Pharma?
Zosano Pharma ™, Inc., formerly named The Macroflux Corporation, is private specialty pharmaceutical company creating better products utilizing innovative drug delivery technology. Zosano’s transdermal microprojection delivery system provides unique benefits including convenient needle-free administration with room temperature stability for various peptides, proteins, small molecules, biopharmaceuticals and vaccines.
keywords:Biotechnology
$242.6M
Total Funding
50
Number of Employees
$7.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Zosano Pharma News
Get Zosano Pharma alerts: A number of hedge funds and other institutional investors have recently modified their holdings of ZSAN. Morgan...
FREMONT, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company,...
In pre-market trading, the share price of Zosano Pharma (NASDAQ:ZSAN) stock is incredibly soaring nearly 3,000%. But the total value of all...
Featured companies: BioVex, FullTurn Media, Humanetics, N Spine, Novitas Capital, Reliant Technologies, Symbios, Vaxart, Virtual Radiologic, Winston Laboratories, Zosano Pharma EXPANDING ITEMS: Stay tuned. Vaxart receives $3.3M for oral vaccines — San Francisco’s Vaxart, a biotech developing n ...
Other Companies in Fremont
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $11.6M | 50 | -7% | N/A |
#2 | $11.6M | 50 | 2% | N/A |
#3 | $11M | 50 | 14% | N/A |
#4 | $9.8M | 50 | 9% | N/A |
#5 | $5.8M | 50 | 43% | N/A |